Digestive System Neoplasms

Showing 1 - 25 of 44

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01 in combination with standard adjuvant therapy
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)

Recruiting
  • Carcinoma
  • +4 more
  • Guangzhou, Guangdong, China
    Lei Zhang
Jun 21, 2023

Esophageal Tumors, Esophageal Diseases, Digestive System Tumors Trial (Camrelizumab, Paclitaxel, Platinum)

Not yet recruiting
  • Esophageal Neoplasms
  • +2 more
  • (no location specified)
Nov 20, 2022

Stomach Tumors, Digestive System Tumors, Tumors Trial in Fuzhou (Camrelizumab, SOX, Surgery)

Active, not recruiting
  • Stomach Neoplasms
  • +5 more
  • Fuzhou, Fujian, China
    The Second Affiliated Hospital of Fujian Medical University
Nov 1, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,

Completed
  • Colorectal Cancer
  • +12 more
  • Anlotinib Hydrochloride
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 12, 2022

Digestive System Tumors, Thoracic Tumors Trial in Lille (Emotional skills, Short free talk and relaxation)

Recruiting
  • Digestive System Neoplasms
  • Thoracic Neoplasms
  • Emotional skills
  • Short free talk and relaxation
  • Lille, France
    Hôpital Calmette,CHU
Jul 4, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

Completed
  • Neoplasms
  • +14 more
  • San Antonio, Texas
    The START Center for Cancer Care
Apr 21, 2022

Palliative Primary Tumor Resection in Minimally Symptomatic

Recruiting
  • Colorectal Neoplasms
  • +12 more
  • Moscow, Russian Federation
    Ryzhikh National Medical Research Center of Coloproctology
Apr 2, 2022

Advanced Solid Tumors, Digestive System Tumors, Pancreatic Cancer Resectable Trial in Beijing (IM96 CAR-T cells)

Recruiting
  • Advanced Solid Tumors
  • +3 more
  • IM96 CAR-T cells
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 10, 2022

Esophageal Squamous Cell Carcinoma, Esophageal Tumors, Esophageal Diseases Trial (Anlotinib HCl, TQB2450)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • +10 more
  • (no location specified)
Feb 19, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

Completed
  • Neoplasms
  • +13 more
  • San Antonio, Texas
    The START Center for Cancer Care
Jan 24, 2022

Carcinoma, Carcinoma, Hepatocellular, Liver Tumors Trial in Guangzhou (Hepatic arterial infusion chemo, Folfox Protocol,

Not yet recruiting
  • Carcinoma
  • +8 more
  • Hepatic arterial infusion chemotherapy
  • +2 more
  • Guangzhou, Guangdong, China
    Lei Zhang
Sep 22, 2021

Digestive System Tumors, Surgery, Surgery--Complications Trial in Rabat, Oujda

Terminated
  • Digestive System Neoplasms
  • +4 more
    • Rabat, Please Enter The State Or Province, Morocco
    • +3 more
    Sep 2, 2021

    Digestive System Tumors Trial in Hong Kong (EUS-guided RFA)

    Recruiting
    • Digestive System Neoplasms
    • EUS-guided RFA
    • Hong Kong, Hong Kong
      Department of Surgery, Prince of Wales Hospital
    Aug 2, 2021

    Spanish Series of Patients Treated With Radionuclide Lutetium177

    Recruiting
    • Neuroendocrine Tumors
    • +17 more
    • Lutetium [177Lu] oxodotreotide/dotatate
    • Santiago De Compostela, A Coruña, Spain
    • +18 more
    Jul 1, 2021

    Digestive System Tumors Trial in China (LP002, Cisplatin, Fluorouracil)

    Unknown status
    • Digestive System Neoplasms
    • Beijing, Beijing, China
    • +5 more
    Feb 12, 2021

    Digestive System Tumors Trial in Nanjing (Parenteral Nutrition)

    Completed
    • Digestive System Neoplasms
    • Parenteral Nutrition
    • Nanjing, Jiangsu, China
      JinlingH
    Sep 26, 2020

    Enteral Nutrition, Postoperative Period, Digestive System Tumors Trial in Nanjing (Enteral nutrition)

    Completed
    • Enteral Nutrition
    • +2 more
    • Enteral nutrition
    • Nanjing, Jiangsu, China
      Jinling Hospital, China
    Sep 21, 2020

    Hepatocellular Carcinoma, Liver Tumors, Digestive System Tumors Trial in Chengdu (TACE combined with sorafenib and PD-1 mAb)

    Recruiting
    • Hepatocellular Carcinoma
    • +7 more
    • TACE combined with sorafenib and PD-1 mAb
    • Chengdu, Sichuan, China
      Sichuan Cancer Hospital and Research Institute
    Sep 14, 2020

    Digestive System Tumors, Thoracic Tumors Trial in Lille (Emotional skills, Relaxation and talking group)

    Terminated
    • Digestive System Neoplasms
    • Thoracic Neoplasms
    • Emotional skills
    • Relaxation and talking group
    • Lille, France
      Hôpital Calmette,CHU
    Sep 8, 2020

    Stomach Tumors, Gastrointestinal Tumors, Stomach Diseases Trial (Apatinib, Capecitabine)

    Not yet recruiting
    • Stomach Neoplasms
    • +7 more
    • (no location specified)
    Mar 23, 2019

    Colorectal Tumors, Intestinal Tumors, Gastrointestinal Tumors Trial in Shenzhen (Apatinib Mesylate Tablets, Bevacizumab

    Unknown status
    • Colorectal Neoplasms
    • +3 more
    • Apatinib Mesylate Tablets
    • Bevacizumab Injection
    • Shenzhen, Guang Dong, China
      Shenzhen People's Hospital
    Jan 20, 2019